[NBY] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
10-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -38.88%
YoY- 28.73%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 1,615 3,142 4,091 3,438 1,200 152 1,099 6.62%
PBT -282 -1,538 -2,447 -3,736 -5,240 -4,219 -3,845 -35.28%
Tax -2,149 -267 281 1,671 2 104 3 -
NP -282 -1,538 -2,447 -3,736 -5,242 -4,219 -3,848 -35.29%
Tax Rate - - - - - - - -
Total Cost 1,897 4,680 6,538 7,174 6,442 4,371 4,947 -14.75%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -17.46 -48.95 -59.81 -108.67 -436.83 -2,775.66 -350.14 -39.31%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.54 -3.15 -5.60 -11.98 -62.04 -72.64 -89.87 -57.34%
EPS Diluted -0.43 -3.14 -5.59 -11.98 -62.04 -72.64 -89.87 -58.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.